Transport time, not transport method, predicts Neisseria gonorrhoeae culture yield in an urban setting
DOI:
https://doi.org/10.33321/cdi.2026.50.011Keywords:
Neisseria gonorrhoeae, bacterial culture, antimicrobial resistance, antimicrobial susceptibility testingAbstract
Antimicrobial resistance (AMR) in Neisseria gonorrhoeae poses a pressing public health threat. Current surveillance programs via antimicrobial susceptibility testing (AST) depend on successfully cultivating the organism via bacterial culture. However, AST is more challenging in extragenital sites and in remote clinical settings where there is a delay between sample collection and testing. This study evaluated whether an enhanced specimen transport system involving direct plating of samples onto selective agar with carbon dioxide enrichment (Bio-BagTM Type C, Becton Dickinson) improved N. gonorrhoeae recoverability compared to the standard method of rayon swabs in Amies gel (TransystemTM, Copan Diagnostics). Men with urethral or rectal gonorrhoea confirmed by nucleic acid amplification testing were consecutively recruited from an urban Sydney clinic. Among 33 rectal samples, enhanced transport yielded a slightly higher culture positivity rate (72.7%) than the standard method (69.7%), though this difference was not statistically significant (p = 0.790). Notably, rectal specimens arriving at the laboratory within five hours had significantly higher culture yields (100%) than those with longer transport times (61.5%; p = 0.049). Future studies of the impact of enhanced transport in rural and remote settings are critical to enhance AMR surveillance.
Downloads
References
World Health Organization (WHO). WHO Gonococcal AMR Surveillance Programme. [Webpage.] Geneva: WHO; 2025. Available from: https://www.who.int/data/gho/data/themes/topics/who-gonococcal-amr-surveillance-programme-who-gasp.
Lahra MM, van Hal S, Hogan TR. Australian Gonococcal Surveillance Programme Annual Report, 2024. Commun Dis Intell (2018). 2025:49. doi: https://doi.org/10.33321/cdi.2025.49.056.
Selvey C, New South Wales State Government Ministry of Health (NSW Health). Antimicrobial resistant gonorrhoea. [Safety information document.] Sydney: NSW Health; 24 April 2025. Available from: https://www.health.nsw.gov.au/sabs/Documents/2025-si-007.pdf.
Nadal-Baron P, Salmerón P, García JN, Trejo-Zahinos J, Sulleiro E, Lopez L et al. Neisseria gonorrhoeae culture growth rates from asymptomatic individuals with a positive nucleic acid amplification test. Lett Appl Microbiol. 2022;75(5):1215–24. doi: https://doi.org/10.1111/lam.13789.
Brendefur Corwin LM, Campbell P, Jakobsen K, Müller F, Lai X, Unemo M et al. Improvement in Neisseria gonorrhoeae culture rates by bedside inoculation and incubation at a clinic for sexually transmitted infections. Ann Clin Microbiol Antimicrob. 2023;22(1):27. doi: https://doi.org/10.1186/s12941-023-00576-0.
van der Veer BMJW, Hoebe CJPA, Dukers-Muijrers NHTM, van Alphen LB, Wolffs PFG. Men and women have similar Neisseria gonorrhoeae bacterial loads: a comparison of three anatomical sites. J Clin Microbiol. 2020;58(11):e01171-20. doi: https://doi.org/10.1128/JCM.01171-20.
Sivaraj V, Ahamed A, Artykov R, Menon-Johansson A, Thomas S. P013 Performance of Gonorrhea culture using Amies swab and culture plates: in-house comparison. [Conference poster.] Birmingham: British Association for Sexual Health and HIV Annual Conference; June/July 2019. doi: https://doi.org/10.13140/RG.2.2.32901.70888.
Al Suwayyid BA, Haese EC, Mowlaboccus S, Pearson JC, Whiley DM, Armstrong PK et al. Travel-associated lineages and unique endemic antimicrobial-susceptible lineages of Neisseria gonorrhoeae predominate in Western Australia. Microb Genom. 2023;9(3):mgen000969. doi: https://doi.org/10.1099/mgen.0.000969.
Ouk V, Heng LS, Virak M, Deng S, Lahra MM, Frankson R et al. High prevalence of ceftriaxone-resistant and XDR Neisseria gonorrhoeae in several cities of Cambodia, 2022–23: WHO Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP). JAC Antimicrob Resist. 2024;6(2):dlae053. doi: https://doi.org/10.1093/jacamr/dlae053.
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2026 Communicable Diseases Intelligence

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
